Replies to post #103637 on Anavex Life Sciences Corp (AVXL)

[rocalinda]

Falcon,

Good perspective as usual.

For me the appointment of Dr. Fadiran is an endorsement from a seasoned FDA insider who believes that Anavex has the goods. Likewise, Dr. Missling continues to shore up the management team in preparation for the critical steps that need to be taken between now and hopefully commercialization.

Obviously, the most important step is to validate the efficacy and continued safety of the drug(s) with positive results from well organized/conducted Ph-3 trials. Until then the market will remain skeptical, albeit with encouraging signs by the increasing number of institutions taking positions in the stock.

Cheers!

[xodcode]

Always appreciate reading your posts, but, on this one I do differ with your narrow trading range outlook.

My technical analysis indicates a 30% move is imminent and points to a move by May 12/17.

Obviously, as a believer in AVXL science, I'm guessing that 30% move will be up.